>AT2G14080.1 | disease resistance protein (TIR-NBS-LRR class) putative
MDFYVFLGTVAATFFTLLGTIFYMIYGKFRVQETIITTSSSPPTSPQSSLSCNQKHDVFP
SFHGADVRKSFLSHILKEFKRKGIDTFIDNNIERSKSIGPELIEAIKGSKIAVVLLSKDY
ASSSWCLNELVEIMKCRKMLDQTVMTIFYEVDPTDVKKQTGDFGKVFKKTCMGKTNAVSR
KWIEALSEVATIAGEHSINWDTEAAMIEKISTDISNKLNNSTPLRDFDGLVGMGAHMEKL
ELLLCLDSCEVRMIGIWGPPGIGKTTIVRFLYNQLSSSFELSIFMENIKTMHTILASSDD
YSAKLILQRQFLSKILDHKDIEIPHLRVLQERLYNKKVLVVLDDVDQSVQLDALAKETRW
FGPRSRILITTQDRKLLKAHRINNIYKVDLPNSDDALQIFCMYAFGQKTPYDGFYKLARK
VTWLVGNFPLGLRVVGSYFREMSKQEWRKEIPRLRARLDGKIESVLKFSYDALCDEDKDL
FLHIACFFNHESIEKLEDFLGKTFLDIAQRFHVLAEKSLISINSNFVEMHDSLAQLGKEI
VRKQSVREPGQRQFLVDARDISEVLADDTAGGRSVIGIYLDLHRNDDVFNISEKAFEGMS
NLQFLRVKNFGNLFPAIVCLPHCLTYISRKLRLLDWMYFPMTCFPSKFNPEFLVELNMWG
SKLEKLWEEIQPLRNLKRMDLFSSKNLKELPDLSSATNLEVLNLNGCSSLVELPFSIGNA
TKLLKLELSGCSSLLELPSSIGNAINLQTIDFSHCENLVELPSSIGNATNLKELDLSCCS
SLKELPSSIGNCTNLKKLHLICCSSLKELPSSIGNCTNLKELHLTCCSSLIKLPSSIGNA
INLEKLILAGCESLVELPSFIGKATNLKILNLGYLSCLVELPSFIGNLHKLSELRLRGCK
KLQVLPTNINLEFLNELDLTDCILLKTFPVISTNIKRLHLRGTQIEEVPSSLRSWPRLED
LQMLYSENLSEFSHVLERITVLELSDINIREMTPWLNRITRLRRLKLSGCGKLVSLPQLS
DSLIILDAENCGSLERLGCSFNNPNIKCLDFTNCLKLDKEARDLIIQATARHYSILPSRE
VHEYITNRAIGSSLTVKLNQRALPTSMRFKACIVLADNGGREAGNEGRMEVYMTIMERQN
DFITSTYVSLNHIFPEFLREHMYTVEVLVDVEVTSDELVFDFQLNSEKWEIGECGVLELK
NHVQTFSEIDSWDNY*
>AT5G44510.1 | TAO1 (TARGET OF AVRB OPERATION1) ATP binding / protein binding / transmembrane receptor
MDSSCFLVYRIFRFRKRNKNISSSLSSSSPPSSLSQNWLHPVFLSFRGEDVRKGLLSHIQ
KEFQRNGITPFIDNEMKRGGSIGPELLQAIRGSKIAIILLSRNYGSSKWCLDELVEIMKC
REELGQTVMTVFYDVDPSDVRKQKGDFGKVFKKTCVGRPEEMVQRWKQALTSAANILGED
SRNWENEADMIIKISKDVSDVLSFTPSKDFDEFVGIEAHTTEITSLLQLDLEEVRMIGIW
GPAGIGKTTISRVLYNKLFHQFQLGAIIDNIKVRYPRPCHDEYSAKLQLQKELLSQMINQ
KDMVVPHLGVAQERLKDKKVLLVLDDVDGLVQLDAMAKDVQWFGLGSRIIVVTQDLKLLK
AHGIKYIYKVDFPTSDEALEIFCMYAFGEKSPKVGFEQIARTVTTLAGKLPLGLRVMGSY
LRRMSKQEWAKSIPRLRTSLDDDIESVLKFSYNSLAEQEKDLFLHITCFFRRERIETLEV
FLAKKSVDMRQGLQILADKSLLSLNLGNIEMHNLLVQLGLDIVRKQSIHKPGKRQFLVDT
EDICEVLTDDTGTRTLIGIDLELSGVIEGVINISERAFERMCNLQFLRFHHPYGDRCHDI
LYLPQGLSHISRKLRLLHWERYPLTCLPPKFNPEFLVKINMRDSMLEKLWDGNEPIRNLK
WMDLSFCVNLKELPDFSTATNLQELRLINCLSLVELPSSIGNATNLLELDLIDCSSLVKL
PSSIGNLTNLKKLFLNRCSSLVKLPSSFGNVTSLKELNLSGCSSLLEIPSSIGNIVNLKK
VYADGCSSLVQLPSSIGNNTNLKELHLLNCSSLMECPSSMLNLTRLEDLNLSGCLSLVKL
PSIGNVINLQSLYLSDCSSLMELPFTIENATNLDTLYLDGCSNLLELPSSIWNITNLQSL
YLNGCSSLKELPSLVENAINLQSLSLMKCSSLVELPSSIWRISNLSYLDVSNCSSLLELN
LVSHPVVPDSLILDAGDCESLVQRLDCFFQNPKIVLNFANCFKLNQEARDLIIQTSACRN
AILPGEKVPAYFTYRATGDSLTVKLNQKYLLQSLRFKACLLLVEGQNKWPNWGMNLVTSR
EPDGHIVLYTPSSHLQGPLLMENLYTFEFELVVTSSEFVLEFRADRYKCALGRFDKFGVH
VVWCHLDQYESKSPSCKPFWRDFPIVISNGQNILDAILKTPMPSINQ*